Pfizer chief executive Albert Bourla said artificial intelligence has the potential to accelerate everything from scanning ...

Despite slowing COVID-19 vaccine sales these healthcare titans are trading at more reasonable valuations with a lot of the ...

Pfizer Inc's chief executive said on Tuesday that almost 250,000 courses of the drugmaker's oral antiviral COVID-19 treatment ...

More than two months after a 150 mph tornado ripped through the Pfizer plant in Rocky Mount, raising nationwide concerns of ...

The US Food and Drug Administration (FDA) has expanded the label for Pfizer’s cancer drug Bosulif (bosutinib) to include its ...

Pfizer resumes production at its North Carolina site damaged by a tornado in July, but says that some medications may not be ...

Pfizer, Inc. (NYSE: PFE) shares are trading lower Wednesday. The stock hit a new 52-week low and has fallen more than 24% ...

Pfizer is partnering up with Boston synthetic biology firm Ginkgo Bioworks, plus other life sciences news you may have missed ...

COMIRNATY Omicron XBB.1.5-adapted monovalent COVID-19 vaccine is now authorized in Canada for individuals 6 months of age and olderNew Omicron ...

The first treatment for acute migraine made by Pfizer Ltd has been recommended by the National Institute for Health and Care ...

By Robb M. Stewart Canada's health regulator cleared the latest Covid-19 shot from Pfizer and partner BioNTech, giving its approval to a second ...

Ginkgo Bioworks (NYSE: DNA) today announced a collaboration with Pfizer (NYSE: PFE) focused on the discovery of RNA-based ...